332 related articles for article (PubMed ID: 17175980)
1. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
Maskey-Warzechowska M; Pankowska M; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
[TBL] [Abstract][Full Text] [Related]
2. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
3. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
[TBL] [Abstract][Full Text] [Related]
4. Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD.
Chhabra SK
J Asthma; 2005 Jun; 42(5):367-72. PubMed ID: 16036411
[TBL] [Abstract][Full Text] [Related]
5. Post-bronchodilator spirometry reference values in adults and implications for disease management.
Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
[TBL] [Abstract][Full Text] [Related]
6. High resolution CT and bronchial reversibility test for diagnosing COPD.
Kurashima K; Takayanagi N; Sato N; Kanauchi T; Hoshi T; Tokunaga D; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M
Respirology; 2005 Jun; 10(3):316-22. PubMed ID: 15955144
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and management of chronic obstructive pulmonary disease].
Sato N; Kanazawa M
Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
10. Significant bronchodilator responsiveness and "reversibility" in a population sample.
Prentice HA; Mannino DM; Caldwell GG; Bush HM
COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
12. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
13. [Stage and prognosis of COPD].
Akashiba T
Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
Barczyk A; Pierzchała W
Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
[TBL] [Abstract][Full Text] [Related]
15. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
16. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
17. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
Zagdańska R; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
[TBL] [Abstract][Full Text] [Related]
18. Classifying the severity of COPD: are the new severity scales better than the old?
Esteban C; Quintana JM; Egurrola M; Moraza J; Aburto M; Pérez-Izquierdo J; Basualdo LV; Capelastegui A
Int J Tuberc Lung Dis; 2009 Jun; 13(6):783-90. PubMed ID: 19460257
[TBL] [Abstract][Full Text] [Related]
19. Argument for changing criteria for bronchodilator responsiveness.
Hansen JE; Sun XG; Adame D; Wasserman K
Respir Med; 2008 Dec; 102(12):1777-83. PubMed ID: 18701269
[TBL] [Abstract][Full Text] [Related]
20. [The diagnosis of COPD is recommendation dependent].
Ben Saad H; Ben Amor L; Ben Mdella S; Ghannouchi I; Ben Essghair M; Bougmiza I; Garrouche A; Rouatbi N; Rouatbi S
Tunis Med; 2014 Jul; 92(7):474-81. PubMed ID: 25775287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
